Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits - Wikidata - thesis-toulmin - TriplyDB

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

http://www.wikidata.org/entity/Q28602816

about

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein Human antibody pieces together the puzzle of the trimeric Lassa virus surface antigen.A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization.Structure-function relationship of the mammarenavirus envelope glycoprotein.Strategies to induce broadly protective antibody responses to viral glycoproteins.Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.Structural basis for antibody-mediated neutralization of Lassa virus.Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.Current status on the development of pseudoviruses for enveloped viruses.Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.Structure of the Lassa virus glycan shield provides a model for immunological resistance Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever An overview of Lassa fever

P2860

Q30402347-5BF12A6F-F1EA-4437-BB28-7028108780F3 Q33365688-6F4F3211-A3CC-46A5-835D-94438B0926A8 Q37833671-170D9CE5-CF12-4940-AD16-081F9E6705E5 Q38662402-0B2160C8-2DC4-4C22-B933-46D612447F24 Q38718346-252F77BA-59F1-4D7A-9874-566CD7695127 Q38937488-CC9A9191-C5FE-4D33-BFC2-9A850681D8A9 Q39170802-FEA89984-9DB0-4599-9B2C-78F81A33DDB6 Q40040779-2D614B49-1EEF-465F-806B-4F85B4DFC3CA Q40054615-F8D2182F-E013-4DF4-AB71-AFC07C8145EB Q40092356-D3E6B932-D8C0-4C68-B686-3FD4DD96BF1F Q47117332-FE968064-30E1-4E37-8FDE-73191D6EBB62 Q47548101-96B35BB2-AFC6-4FC4-97BD-081F55D2189B Q47568014-C5A002F9-74FA-444F-9EAC-0B3E28B55FA5 Q52590886-8A2E0323-0AEA-404A-96EA-8DD661F0608F Q52723914-A9B60E29-46A5-440C-AA82-5F85534CBDC6 Q54258792-C121FE91-5220-4BCD-B34F-FC6B40DED353 Q55306089-523B41FD-92D7-4676-ACC3-CCECA64D09DA Q56941600-6265B67C-9394-44BD-A324-31D5ED7BBA3C Q57476548-471192D8-34F8-400A-B72E-EDEDBD99EC74 Q71419342-6bd0458b-4103-40ee-ecca-4d1e1f47aade

P2860

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

http://www.wikidata.org/entity/Q28602816

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@ast

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@en

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@nl

type

label

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@ast

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@en

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@nl

prefLabel

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@ast

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@en

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@nl

P1433

Q28602816-1B6D0276-150B-44D4-A2BD-65EC1A6F1422

P1476

Q28602816-C508BB9F-E82E-42D1-B93E-F609407A53DF

P2093

Q28602816-0335CD93-6EDD-411F-8305-BA3F507D129A

Q28602816-0D07D6E3-B4E1-40BF-9CE7-21CEDCC30CF5

Q28602816-0EACD9AC-4742-4DEE-B7A5-0DA606D0790B

Q28602816-101DE2BB-8FF7-4CC0-B5CE-2073B22AC699

Q28602816-1454FAE0-C2B5-47A0-B7FD-EBD12970A52E

Q28602816-22255C75-976F-4779-A05D-967BB0FB1F90

Q28602816-253C06F3-8EF4-439C-8827-1F37ED763DBD

Q28602816-25DCFE48-8878-4926-89B3-AB6438AB96D3

Q28602816-2A264EA7-700D-45FB-ADDF-1651BA5CCF7E

Q28602816-303BF5B2-5631-4402-A14A-FB78B58D0FBD

P2860

Q28602816-0EC5E17E-464D-4F20-AA8C-A678F35375CF

Q28602816-0FA6A6CE-3CA6-4EE5-B488-FF1658F7F737

Q28602816-0FF34A78-AA8A-4231-8D07-7ADDFC8E4C5A

Q28602816-13E101B7-D785-4CF4-A5AF-F7CE86791EE0

Q28602816-19EDA81B-D94F-4034-ACC4-E9F254FD42EF

Q28602816-25069BB9-C2A1-4DA1-AF17-E69A577EF492

Q28602816-29BF899C-8547-43E3-BA15-77A6B8E808B6

Q28602816-2A199CC1-90AE-4A30-B6EF-941F2CB9A036

Q28602816-2BC5A54D-611D-445E-AF2E-A47D2744D44C

Q28602816-2DD3599C-CE17-4A39-90F4-613A52D6A3C8

P2888

Q28602816-7299CC73-C6F5-44A3-BCC4-DAAD01126110

P304

Q28602816-3C924B8D-3B38-4C50-8AD0-316AC67129B7

P31

Q28602816-3CB8A865-B40A-484D-AB36-FFD0E3DAE44E

P3181

Q28602816-48323DE9-2C3B-4A4C-8858-B59F2E85286E

P356

Q28602816-06398E6C-7D1C-46E4-97DC-DD178BC38C8A

P407

Q28602816-D552052B-AD5D-4FA2-BDE5-7146B91EE7F8

P478

Q28602816-4205B759-FC03-4F51-B9C0-12237FC95EDE

P50

Q28602816-12C66F6B-1C3B-4D93-9A41-63F553FEE3FA

Q28602816-4EA122D4-5731-493C-A0E9-141529043582

Q28602816-6AD93B83-69E3-4276-B59C-154FEC37D2FA

Q28602816-70A32736-15BD-481C-A3AF-05F6FE1CA8B9

Q28602816-8B4F3B44-71E2-408F-A527-75A960017AC5

Q28602816-B6DA3EC9-03C0-48B8-8C34-81E73A253B3E

Q28602816-B9EDF88E-757D-44C2-9698-3B85481DAB39

Q28602816-C1B8A862-F75C-4810-9D38-9F6F33B918E5

Q28602816-C9158973-9439-4DF4-8797-306C5F1D09F1

Q28602816-F1729CB9-1090-4A54-810D-AF410231C2C0

P577

Q28602816-AB10AADE-0EB0-4CEB-9F39-D4805AF04A88

P5875

Q28602816-D3EA91D7-F680-4107-AF9C-F683316B3A2F

P6179

Q28602816-F85770C6-462F-4575-AEFF-53C2EC62E289

P698

Q28602816-F5788C72-6614-4163-B5B9-9C23EC3A619A

P921

Q28602816-48601CFB-74D3-4D4D-94E2-B13837DA607C

Q28602816-A69CA1C3-182C-4346-B2E9-CB91ED4E233E

P932

Q28602816-DEB760A3-23A9-4BA1-8D87-68EABD9AD2EF

P3181

P356

P1433

Nature Communications

P1476

Most neutralizing human monocl ...... sa virus glycoprotein subunits

@en

P2093

Ashley A Smira

http://www.w3.org/2001/XMLSchema#string

Benjamin T Bradley

http://www.w3.org/2001/XMLSchema#string

Benson Cheng

http://www.w3.org/2001/XMLSchema#string

Chandrika B Kannadka

http://www.w3.org/2001/XMLSchema#string

Courtney E Garry

http://www.w3.org/2001/XMLSchema#string

Danny A Asogun

http://www.w3.org/2001/XMLSchema#string

Deborah H Elliott

http://www.w3.org/2001/XMLSchema#string

Donald S Grant

http://www.w3.org/2001/XMLSchema#string

Haini Yu

http://www.w3.org/2001/XMLSchema#string

James E Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol.

Lassa fever in post-conflict sierra leone

Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation

Proof of principle for epitope-focused vaccine design

Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

Coot: model-building tools for molecular graphics

Antibody neutralization and escape by HIV-1

P2888

P304

11544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1763392

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NCOMMS11544

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Erica Ollmann Saphire

Kristian G. Andersen

Pardis C. Sabeti

Thomas W Geisbert

Christian T. Happi

P577

2016-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

302916844

http://www.w3.org/2001/XMLSchema#string

P6179

1023070383

http://www.w3.org/2001/XMLSchema#string

P698

27161536

http://www.w3.org/2001/XMLSchema#string

P921

P932

4866400

http://www.w3.org/2001/XMLSchema#string